Goal-oriented transgenic TCR-T cell design for efficient cancer immunotherapy 2266120
Adoptive cell transfer (ACT) therapy is a promising approach for cancer treatment facing several limitations. Tumor-infiltrating lymphocyte (TILs) therapy is limited by patient condition and tumor accessibility. Peripheral lymphocyte redirection strategies by low transduction efficiency and potency. We previously...